New York, NY, United States of America

Manuel Ascano, Jr

USPTO Granted Patents = 6 

 

Average Co-Inventor Count = 9.9

ph-index = 3

Forward Citations = 55(Granted Patents)


Company Filing History:


Years Active: 2014-2021

Loading Chart...
Loading Chart...
6 patents (USPTO):

Title: The Innovations of Manuel Ascano, Jr.

Introduction

Manuel Ascano, Jr. is a prominent inventor based in New York, NY, known for his significant contributions to the field of biochemistry and molecular biology. With a total of six patents to his name, Ascano has made remarkable strides in understanding and manipulating cellular signaling pathways.

Latest Patents

Among his latest patents, one notable invention is focused on "Compositions and methods for altering second messenger signaling." This patent provides compounds comprising cyclic dinucleotides containing a 2',5' linkage, which are useful in the design of research tools and therapeutic modalities such as enzyme modulators. Another significant patent also titled "Compositions and methods for altering second messenger signaling" relates to the use and exploitation of isomers of cGAMP, as well as the structure of the enzyme cGAS.

Career Highlights

Throughout his career, Ascano has worked with esteemed institutions such as Memorial Sloan Kettering Cancer Center and Rutgers, the State University of New Jersey. His work has been instrumental in advancing research in cancer biology and therapeutic development.

Collaborations

Ascano has collaborated with notable scientists, including Thomas Tuschl and Dinshaw J Patel, further enhancing the impact of his research through shared expertise and innovative ideas.

Conclusion

Manuel Ascano, Jr. continues to be a driving force in the field of biochemistry, with his patents paving the way for new research tools and therapeutic strategies. His contributions are vital to the ongoing exploration of cellular mechanisms and their implications in health and disease.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…